Few molecules have generated more excitement - and more commercial activity - in longevity science over the past decade than NAD+. Nicotinamide adenine dinucleotide is a coenzyme found in every cell in the body, and its decline with age has become one of the most discussed phenomena in aging research.

The interest is not unfounded. NAD+ sits at the center of cellular energy metabolism and is the essential fuel for a class of proteins called sirtuins - enzymes that regulate DNA repair, inflammation, metabolism, and stress resistance. When NAD+ falls, sirtuin activity falls with it. And NAD+ does fall, substantially, with age.

Understanding what this means - and what, if anything, can be done about it - requires separating the genuine science from the considerable commercial noise that surrounds it.

NAD+ has two primary roles in the cell.

Energy metabolism. NAD+ is a critical electron carrier in the mitochondrial electron transport chain - the process by which cells convert nutrients into ATP. Without adequate NAD+, mitochondrial function is impaired and cellular energy production declines.

Sirtuin activation. Sirtuins are a family of seven proteins (SIRT1 through SIRT7) that use NAD+ as a substrate to perform deacetylation reactions - removing acetyl groups from target proteins to change their activity. This process consumes NAD+, which is why sirtuin activity is directly dependent on NAD+ availability.

Sirtuins are sometimes called longevity proteins, and the label is not entirely unearned. Their functions are broad and deeply relevant to aging:

SIRT1 deacetylates and activates FOXO3 (the longevity transcription factor), promotes autophagy, suppresses NF-kB-driven inflammation, and regulates circadian clock genes. It is activated by caloric restriction and fasting.

SIRT3 is the primary mitochondrial sirtuin. It activates antioxidant enzymes, regulates fatty acid oxidation, and protects against age-related mitochondrial dysfunction.

SIRT6 is a DNA repair sirtuin. It promotes the repair of double-strand DNA breaks and suppresses the expression of inflammatory genes. Mice overexpressing SIRT6 live significantly longer than controls.

SIRT7 regulates ribosomal DNA transcription and the stress response in the nucleus.

The common thread across sirtuins is that they promote cellular maintenance over cellular growth - the same trade-off that characterizes caloric restriction and fasting.

NAD+ levels in human tissue decline substantially with age. Studies measuring NAD+ in muscle, blood, and skin consistently find that levels in people in their 60s are roughly half what they were in their 20s and 30s.

The mechanisms behind this decline are multiple:

• Increased activity of CD38, an enzyme that degrades NAD+, which rises with age and with inflammation
• Reduced expression of NAMPT, the rate-limiting enzyme in the primary NAD+ biosynthesis pathway
• Increased DNA damage with age, which activates PARP enzymes that consume large amounts of NAD+ in repair attempts
• Mitochondrial dysfunction, which both results from and contributes to NAD+ decline

The consequence is a self-reinforcing cycle: lower NAD+ impairs mitochondrial function and DNA repair, which increases damage, which further depletes NAD+.

The commercial response to NAD+ decline has been the development of oral precursor supplements - primarily nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are converted to NAD+ in the body through the salvage pathway.

The animal data is genuinely impressive. In mice, NMN and NR supplementation raises tissue NAD+ levels, improves mitochondrial function, enhances insulin sensitivity, reduces age-related weight gain, improves muscle function, and in some studies extends lifespan.

The human data is more limited but emerging:

NR studies have consistently shown that oral NR raises blood NAD+ levels in humans. A 2018 study in Nature Communications found that NR supplementation increased blood NAD+ by approximately 60% in healthy middle-aged adults. A 2020 study found that NR improved muscle NAD+ metabolism in older adults.

NMN studies have shown similar blood NAD+ elevation. A 2021 Japanese study found that NMN supplementation improved muscle insulin sensitivity and physical performance in older men. A 2022 Washington University study found that NMN improved muscle function and insulin signaling in postmenopausal women with prediabetes.

What the human studies have not yet shown is a clear effect on longevity outcomes - reduced mortality, reduced disease incidence, or extended healthspan in large, long-term trials. The studies to date have been small, short, and focused on biomarkers rather than clinical endpoints.

The NAD+ story is scientifically compelling and commercially overhyped simultaneously. Here is where the evidence actually stands:

What is well established: NAD+ declines with age. Sirtuins depend on NAD+. Sirtuin activity is associated with longevity in multiple organisms. NMN and NR raise blood NAD+ in humans.

What is not yet established: Whether raising blood NAD+ with supplements translates to meaningful improvements in human healthspan or lifespan. Whether the tissue NAD+ increases that matter (in muscle, brain, liver) are achieved by oral supplementation. Whether the benefits seen in mice translate to humans at all.

The dose question: The doses used in human studies (250-1000mg/day of NMN or NR) are substantially higher than what most commercial supplements provide, and the costs are significant.

Safety: Both NMN and NR appear safe in the doses studied. No serious adverse effects have been reported in human trials to date.

The most evidence-backed ways to support NAD+ levels and sirtuin activity do not require supplements:

Exercise. Both aerobic and resistance exercise activate AMPK, which upregulates NAMPT - the rate-limiting enzyme in NAD+ synthesis. Exercise is the most reliable way to raise NAD+ in muscle tissue.

Caloric restriction and fasting. These interventions activate sirtuins through multiple mechanisms, including raising NAD+ by reducing its consumption and upregulating biosynthesis.

Avoiding chronic alcohol consumption. Alcohol metabolism consumes NAD+ and chronically depletes it in the liver.

Reducing chronic inflammation. Inflammation activates CD38, the primary NAD+-degrading enzyme. Anything that reduces chronic inflammation - exercise, sleep, dietary quality - helps preserve NAD+.

Adequate niacin (vitamin B3). Niacin is a precursor to NAD+ through a different pathway. Severe niacin deficiency (pellagra) causes dramatic NAD+ depletion. Most people in developed countries are not deficient, but adequate dietary niacin supports baseline NAD+ synthesis.

No discussion of sirtuins is complete without addressing resveratrol - the red wine compound that was briefly the most famous sirtuin activator in the world. Early research suggested resveratrol directly activated SIRT1, generating enormous excitement and a wave of supplements.

Subsequent research complicated the picture significantly. The original assay used to measure SIRT1 activation by resveratrol was found to be artifactual. Large clinical trials of resveratrol have not shown the benefits predicted by the early animal studies. The resveratrol story is a cautionary tale about the gap between exciting preliminary findings and clinical reality - a gap that the NAD+ story may also be navigating.

If you are considering NMN or NR supplementation, the honest answer is that the science is promising but not yet definitive for humans. The animal data is compelling. The human biomarker data is encouraging. The clinical outcome data does not yet exist.

If you choose to supplement, the doses used in human studies (500mg/day of NMN or NR) are substantially higher than most commercial products provide. Quality and purity vary widely across manufacturers.

More importantly, the lifestyle interventions that support NAD+ and sirtuin activity - regular exercise, caloric moderation, quality sleep, reduced alcohol - have far more evidence behind them than any supplement. They are also free.

The NAD+ pathway is genuinely important to aging biology. Whether supplementing it will prove to be a meaningful longevity intervention in humans is a question the next decade of research will answer.